Brian Skorney
Stock Analyst at Robert W. Baird
(0.12)
# 4,384
Out of 4,468 analysts
850
Total ratings
36.7%
Success rate
-5.6%
Average return
Main Sectors:
Stocks Rated by Brian Skorney
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintained: Buy | $27 → $32 | $13.28 | +140.96% | 18 | Jun 23, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $433 → $400 | $318.52 | +25.58% | 3 | Jun 2, 2026 | |
| ANRO Alto Neuroscience | Maintained: Buy | $38 → $36 | $24.78 | +45.28% | 15 | May 18, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $112 → $129 | $125.59 | +2.72% | 43 | May 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $209 → $252 | $243.47 | +3.50% | 2 | May 6, 2026 | |
| AXSM Axsome Therapeutics | Maintained: Buy | $241 → $246 | $244.31 | +0.69% | 3 | May 5, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $63 → $97 | $60.96 | +59.12% | 6 | Mar 9, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $22 → $20 | $19.28 | +3.73% | 108 | Feb 26, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $108 → $145 | $131.27 | +10.46% | 81 | Feb 11, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Hold | $637 → $742 | $654.27 | +13.41% | 63 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $250 | $216.12 | +15.68% | 97 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $42.23 | +46.82% | 16 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $52 | $15.96 | +225.81% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $186 | $174.26 | +6.74% | 52 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $32 | $23.07 | n/a | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $26.50 | n/a | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $325 → $320 | $528.04 | n/a | 58 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $13.22 | n/a | 1 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $20 | $15.11 | n/a | 37 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $4.69 | n/a | 5 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.87 | n/a | 24 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $215 | $374.15 | n/a | 51 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $23.97 | n/a | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $30 | $4.60 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7.5 | $0.2489 | n/a | 14 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $28.26 | n/a | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $16.93 | n/a | 24 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $38.79 | n/a | 16 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $27.74 | n/a | 14 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $13.09 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $7.73 | n/a | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $39 | $3.30 | n/a | 6 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 → $146 | $17.56 | n/a | 5 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.78 | n/a | 11 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.3466 | n/a | 8 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $144 | $63.42 | n/a | 1 | Mar 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $83 → $138 | $297.65 | n/a | 5 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $42 | $111.60 | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $58.99 | n/a | 11 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $13 | $22.31 | n/a | 7 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.10 | n/a | 3 | Jan 22, 2015 |
REGENXBIO
Jun 23, 2026
Maintained: Buy
Price Target: $27 → $32
Current: $13.28
Upside: +140.96%
Praxis Precision Medicines
Jun 2, 2026
Maintained: Buy
Price Target: $433 → $400
Current: $318.52
Upside: +25.58%
Alto Neuroscience
May 18, 2026
Maintained: Buy
Price Target: $38 → $36
Current: $24.78
Upside: +45.28%
Mirum Pharmaceuticals
May 7, 2026
Maintained: Buy
Price Target: $112 → $129
Current: $125.59
Upside: +2.72%
Jazz Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $209 → $252
Current: $243.47
Upside: +3.50%
Axsome Therapeutics
May 5, 2026
Maintained: Buy
Price Target: $241 → $246
Current: $244.31
Upside: +0.69%
Xenon Pharmaceuticals
Mar 9, 2026
Maintained: Buy
Price Target: $63 → $97
Current: $60.96
Upside: +59.12%
Sarepta Therapeutics
Feb 26, 2026
Maintained: Hold
Price Target: $22 → $20
Current: $19.28
Upside: +3.73%
Gilead Sciences
Feb 11, 2026
Maintained: Hold
Price Target: $108 → $145
Current: $131.27
Upside: +10.46%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintained: Hold
Price Target: $637 → $742
Current: $654.27
Upside: +13.41%
Oct 31, 2025
Maintained: Buy
Price Target: $255 → $250
Current: $216.12
Upside: +15.68%
Sep 26, 2025
Maintained: Buy
Price Target: $62
Current: $42.23
Upside: +46.82%
Aug 12, 2025
Maintained: Buy
Price Target: $57 → $52
Current: $15.96
Upside: +225.81%
Jul 31, 2025
Maintained: Buy
Price Target: $180 → $186
Current: $174.26
Upside: +6.74%
Jun 18, 2025
Maintained: Buy
Price Target: $46 → $32
Current: $23.07
Upside: n/a
Feb 7, 2025
Maintained: Buy
Price Target: $25 → $17
Current: $26.50
Upside: n/a
Jan 31, 2025
Maintained: Sell
Price Target: $325 → $320
Current: $528.04
Upside: n/a
Dec 12, 2024
Initiated Coverage: Buy
Price Target: $30
Current: $13.22
Upside: n/a
Nov 26, 2024
Maintained: Buy
Price Target: $26 → $20
Current: $15.11
Upside: n/a
Nov 20, 2024
Maintained: Buy
Price Target: $28
Current: $4.69
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: $4
Current: $4.87
Upside: n/a
Sep 24, 2024
Rated: Sell
Price Target: $215
Current: $374.15
Upside: n/a
Sep 5, 2024
Initiated Coverage: Buy
Price Target: $26
Current: $23.97
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $28 → $30
Current: $4.60
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $7.5
Current: $0.2489
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $28
Current: $28.26
Upside: n/a
Nov 7, 2022
Maintained: Hold
Price Target: $8
Current: $16.93
Upside: n/a
Sep 8, 2022
Maintained: Hold
Price Target: $6
Current: $38.79
Upside: n/a
Mar 31, 2022
Maintained: Buy
Price Target: $15
Current: $27.74
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $16
Current: $13.09
Upside: n/a
Aug 12, 2021
Initiated Coverage: Buy
Price Target: $34
Current: $7.73
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: $39
Current: $3.30
Upside: n/a
Aug 5, 2021
Maintained: Hold
Price Target: $85 → $146
Current: $17.56
Upside: n/a
May 10, 2021
Maintained: Hold
Price Target: $6
Current: $3.78
Upside: n/a
Nov 1, 2018
Maintained: Buy
Price Target: $7 → $3
Current: $0.3466
Upside: n/a
Mar 27, 2018
Maintained: Buy
Price Target: $144
Current: $63.42
Upside: n/a
Feb 28, 2018
Reiterated: Hold
Price Target: $83 → $138
Current: $297.65
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $32 → $42
Current: $111.60
Upside: n/a
Oct 3, 2017
Reiterated: Buy
Price Target: $115
Current: $58.99
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $14 → $13
Current: $22.31
Upside: n/a
Jan 22, 2015
Reiterated: Buy
Price Target: $11
Current: $5.10
Upside: n/a